Volume 27, Issue 27, 2020
Meet Our Editorial Board Member
Pp: 4437-4437
Author(s): Dominique Heymann
DOI: 10.2174/092986732727200619162346
Cardiovascular Disease: From Diagnosis to Therapy
Pp: 4438-4439
Author(s): Dimitris Tousoulis and Nikolaos Papageorgiou*
DOI: 10.2174/092986732727200619175755
Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?
Pp: 4440-4468
Author(s): Effimia Zacharia*, Konstantinos Zacharias, George-Angelo Papamikroulis , Dimitrios Bertsias, Antigoni Miliou, Zoi Pallantza , Nikolaos Papageorgiou and Dimitris Tousoulis
DOI: 10.2174/0929867327666191213104841
Predictive Role of BNP/NT-proBNP in Non-Heart Failure Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Systematic Review
Pp: 4469-4478
Author(s): Nikolaos Papageorgiou *, Rui Providência, Debbie Falconer, Tanakal Wongwarawipat, Dimitris Tousoulis, Wei Yao Lim , Anthony W. Chow, Richard J. Schilling and Pier D. Lambiase
DOI: 10.2174/0929867326666191213095554
The Predictive Role for ST2 in Patients with Acute Coronary Syndromes and Heart Failure
Pp: 4479-4493
Author(s): Vasiliki Tsigkou*, Gerasimos Siasos*, Evanthia Bletsa, Maria-Evi Panoilia, Angeliki Papastavrou, Georgios Kokosias, Evangelos Oikonomou, Nikolaos Papageorgiou, Marina Zaromitidou, Georgios Marinos, Manolis Vavuranakis, Christodoulos Stefanadis, Athanasios G. Papavassiliou and Dimitris Tousoulis
DOI: 10.2174/0929867326666191016121630
Dyslipidaemias and Cardiovascular Disease: Focus on the Role of PCSK9 Inhibitors
Pp: 4494-4521
Author(s): Olga Panagiotopoulou, Scott T. Chiesa, Dimitrios Tousoulis and Marietta Charakida*
DOI: 10.2174/0929867326666190827151012
Management of Patients with Heart Failure: Focus on New Pharmaceutical and Device Options
Pp: 4522-4535
Author(s): Alexandros Briasoulis*, Chakradhari Inampudi*, Georgios Hatzis and Rabea Asleh
DOI: 10.2174/0929867326666190523083747
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
Pp: 4536-4541
Author(s): Michele Costanzo, Maria Anna Rachele De Giglio and Giovanni Nicola Roviello*
DOI: 10.2174/0929867327666200416131117
In Vitro Data of Current Therapies for SARS-CoV-2
Pp: 4542-4548
Author(s): Ioanna A. Anastasiou, Ioanna Eleftheriadou, Anastasios Tentolouris, Dimitrios Tsilingiris and Nikolaos Tentolouris*
DOI: 10.2174/0929867327666200513075430
Protein Microarrays: Valuable Tools for Ocular Diseases Research
Pp: 4549-4566
Author(s): María Garranzo-Asensio, Ana Montero-Calle, Guillermo Solís-Fernández, Rodrigo Barderas and Ana Guzman-Aranguez*
DOI: 10.2174/0929867326666190627131300
Tubulin Maytansine Site Binding Ligands and their Applications as MTAs and ADCs for Cancer Therapy
Pp: 4567-4576
Author(s): Shuo Cao, Yue-Hui Dong, De-Feng Wang and Zhao-Peng Liu*
DOI: 10.2174/0929867327666200316144610
Commentary on “Non-Steroidal Anti-inflammatory Drugs Loaded Liposomes for Topical Treatment of Inflammatory and Degenerative Conditions” by Carla Matos, FP-ENAS-UFP Energy, Environment and Health Research Unit/CEBIMED-Centro de Estudos em Biomedicina, Fernando Pessoa University, Porto, Portugal Challenges and Prospects of Topical Treatment of Inflammatory and Degenerative Conditions: A Vesicular Approach
Pp: 4577-4578
Author(s): Maha Nasr*
DOI: 10.2174/092986732727200619175649